ArticleEMBO reports2026
Governing the AI-biotech convergence : The rapid progress in and the dual-use nature of biotechnology and AI requires adaptive and resilient regulatory frameworks to address potential risks.
Benjamin D Trump et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it